Drug
Hmpl A580
Hmpl A580: highest development phase Phase 1/2, developed by Hutchmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Hutchmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| HMPL-A580 NCT07396584 | Phase 1/2 | Solid Tumors, Adult |
Latest
No recent events.
Follow Hmpl A580 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.